CP and Middle East respiratory syndrome: Convalescent plasma (CP) from recovered patients has been used previously as a passive immunotherapy in epidemics associated with coronaviruses, SARS CoV-1 in 2003, Middle East respiratory syndrome (MERS) in 2012, and also in the current COVID-19 pandemic [5].